Bo Verberckmoes

Barriers and facilitators to cervical cancer screening among under-screened women in Cuenca, Ecuador: the perspectives of women and health professionals

Bernardo Vega, Vivian Alejandra Neira, José Ortíz et al. · BMC Public Health · 2022 · 40 citations · Full text

Medicine, Health Promotion, Preventive Medicine +17

Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women

Katrina Perehudoff, Heleen Vermandere, A. Paul Williams et al. · BMC International Health and Human Rights · 2020 · 23 citations · Full text

Law, Health Policy, Human Rights Law +17

<i>In Situ</i> Complexation of sgRNA and Cas12a Improves the Performance of a One-Pot RPA–CRISPR-Cas12 Assay

Jake M. Lesinski, Thomas Moragues, Prerit Mathur et al. · Analytical Chemistry · 2024 · 23 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +12

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples

Margo Bell, Bo Verberckmoes, Janne Devolder et al. · Microbiology Spectrum · 2023 · 21 citations · Full text

Medicine, Gynecology, Pathology +17

FRETting about CRISPR-Cas Assays: Dual-Channel Reporting Lowers Detection Limits and Times-to-Result

Jake M. Lesinski, Nathan Khosla, Carolina Paganini et al. · ACS Sensors · 2024 · 11 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +13